Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2019 Mar 16

PMID 30873179

Citations 181

Authors

Anna E Vilgelm

Ann Richmond

Affiliations

Soon will be listed here.

Abstract

Chemokines are small secreted proteins that orchestrate migration and positioning of immune cells within the tissues. Chemokines are essential for the function of the immune system. Accumulating evidence suggest that chemokines play important roles in tumor microenvironment. In this review we discuss an association of chemokine expression and activity within the tumor microenvironment with cancer outcome. We summarize regulation of immune cell recruitment into the tumor by chemokine-chemokine receptor interactions and describe evidence implicating chemokines in promotion of the "inflamed" immune-cell enriched tumor microenvironment. We review both tumor-promoting function of chemokines, such as regulation of tumor metastasis, and beneficial chemokine roles, including stimulation of anti-tumor immunity and response to immunotherapy. Finally, we discuss the therapeutic strategies target tumor-promoting chemokines or induce/deliver beneficial chemokines within the tumor focusing on pre-clinical studies and clinical trials going forward. The goal of this review is to provide insight into comprehensive role of chemokines and their receptors in tumor pathobiology and treatment.

Citing Articles

Suppression of Hepatocellular Carcinoma through Apoptosis Induction by Total Alkaloids of Gelsemium elegans Benth.

Jin M, Li Y, Zhou H, Zhao Y, Zhao X, Yang M Chin J Integr Med. 2025; .

PMID: 40053191 DOI: 10.1007/s11655-025-4121-5.

Bystander Expression of Atypical Chemokine Receptor 2 Protects T Cells from Chemoattraction towards Cancer-Associated Fibroblasts.

Tang R, Tay S, Sharbeen G, Herrmann D, Youkhana J, Timpson P Eur J Immunol. 2025; 55(2):e202451215.

PMID: 39931761 PMC: 11811810. DOI: 10.1002/eji.202451215.

Tumor microbiome: roles in tumor initiation, progression, and therapy.

Zhang S, Huang J, Jiang Z, Tong H, Ma X, Liu Y Mol Biomed. 2025; 6(1):9.

PMID: 39921821 PMC: 11807048. DOI: 10.1186/s43556-025-00248-9.

Combined PARP14 inhibition and PD-1 blockade promotes cytotoxic T cell quiescence and modulates macrophage polarization in relapsed melanoma.

Leshem R, Sefton K, Wong C, Lin I, Isaac D, Niepel M J Immunother Cancer. 2025; 13(1).

PMID: 39870492 PMC: 11772928. DOI: 10.1136/jitc-2024-010683.

The role and therapeutic targeting of the CCL2/CCR2 signaling axis in inflammatory and fibrotic diseases.

Guo S, Zhang Q, Guo Y, Yin X, Zhang P, Mao T Front Immunol. 2025; 15():1497026.

PMID: 39850880 PMC: 11754255. DOI: 10.3389/fimmu.2024.1497026.

References

Hamann A, Syrbe U . T-cell trafficking into sites of inflammation. Rheumatology (Oxford). 2000; 39(7):696-9. DOI: 10.1093/rheumatology/39.7.696. View

Reinhardt R, Khoruts A, Merica R, ZELL T, Jenkins M . Visualizing the generation of memory CD4 T cells in the whole body. Nature. 2001; 410(6824):101-5. DOI: 10.1038/35065111. View

Saji H, Koike M, Yamori T, Saji S, Seiki M, Matsushima K . Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer. 2001; 92(5):1085-91. DOI: 10.1002/1097-0142(20010901)92:5<1085::aid-cncr1424>3.0.co;2-k. View

Henning G, Ohl L, Junt T, Reiterer P, Brinkmann V, Nakano H . CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720. J Exp Med. 2001; 194(12):1875-81. PMC: 2193576. DOI: 10.1084/jem.194.12.1875. View

Azenshtein E, Luboshits G, Shina S, Neumark E, Shahbazian D, Weil M . The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res. 2002; 62(4):1093-102. View

Ueno T, Hara K, Willis M, Malin M, Hopken U, Gray D . Role for CCR7 ligands in the emigration of newly generated T lymphocytes from the neonatal thymus. Immunity. 2002; 16(2):205-18. DOI: 10.1016/s1074-7613(02)00267-4. View

Murphy P . International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev. 2002; 54(2):227-9. DOI: 10.1124/pr.54.2.227. View

Dong H, Strome S, Salomao D, Tamura H, Hirano F, Flies D . Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002; 8(8):793-800. DOI: 10.1038/nm730. View

Ato M, Stager S, Engwerda C, Kaye P . Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol. 2002; 3(12):1185-91. DOI: 10.1038/ni861. View

10.

Kim C, Nagata K, Butcher E . Dendritic cells support sequential reprogramming of chemoattractant receptor profiles during naive to effector T cell differentiation. J Immunol. 2003; 171(1):152-8. DOI: 10.4049/jimmunol.171.1.152. View

11.

Varney M, Li A, Dave B, Bucana C, Johansson S, Singh R . Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype. Clin Exp Metastasis. 2004; 20(8):723-31. DOI: 10.1023/b:clin.0000006814.48627.bd. View

12.

Richmond A, Fan G, Dhawan P, Yang J . How do chemokine/chemokine receptor activations affect tumorigenesis?. Novartis Found Symp. 2004; 256:74-89. View

13.

Zou L, Barnett B, Safah H, LaRussa V, Evdemon-Hogan M, Mottram P . Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 2004; 64(22):8451-5. DOI: 10.1158/0008-5472.CAN-04-1987. View

14.

Varney M, Johansson S, Singh R . Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Am J Clin Pathol. 2006; 125(2):209-16. DOI: 10.1309/VPL5-R3JR-7F1D-6V03. View

15.

Castellino F, Huang A, Altan-Bonnet G, Stoll S, Scheinecker C, Germain R . Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature. 2006; 440(7086):890-5. DOI: 10.1038/nature04651. View

16.

Bajenoff M, Egen J, Koo L, Laugier J, Brau F, Glaichenhaus N . Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity. 2006; 25(6):989-1001. PMC: 2692293. DOI: 10.1016/j.immuni.2006.10.011. View

17.

Raman D, Baugher P, Thu Y, Richmond A . Role of chemokines in tumor growth. Cancer Lett. 2007; 256(2):137-65. PMC: 2065851. DOI: 10.1016/j.canlet.2007.05.013. View

18.

Link A, Vogt T, Favre S, Britschgi M, Acha-Orbea H, Hinz B . Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol. 2007; 8(11):1255-65. DOI: 10.1038/ni1513. View

19.

Schoenborn J, Wilson C . Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007; 96:41-101. DOI: 10.1016/S0065-2776(07)96002-2. View

20.

Pham T, Okada T, Matloubian M, Lo C, Cyster J . S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity. 2008; 28(1):122-33. PMC: 2691390. DOI: 10.1016/j.immuni.2007.11.017. View